Inhaled bronchodilators relax constricted airways and treat the noisy part of asthma: coughing, wheezing, choking and shortness of breath.

Similar documents
First to Market or 505 (b)2 CMC Considerations IPAC-RS/UF Orlando Inhalation Conference Orlando, Florida

Diagnosis and Management of Asthma

Foundations of Pharmacology

Select Inhaled Respiratory Agents

Asthma medications: Know your options - MayoClinic.com. Asthma medications: Know your options

A Visual Approach to Simplifying Respiratory Drug Regimens

A Visual Approach to Simplifying Respiratory Drug Regimens

A Visual Approach to Simplifying Respiratory Drug Regimens

Asthma. Definition. Symptoms

Inhaled Corticosteroid Dose Comparison in Asthma

II: Moderate Worsening airflow limitations Dyspnea on exertion, cough, and sputum production; patient usually seeks medical

End Stage COPD Guidance Document

Ferris State University College of Pharmacy MPA CE Symposium 2016 Paul Thill, PharmD, BCPS

TRELEGY ELLIPTA (fluticasone-umeclidinium-vilanterol) aerosol powder

Respiratory Medications and Devices Update 2/15

Medications Affecting The Respiratory System

FASENRA (benralizumab)

AIRDUO RESPICLICK (fluticasone-salmeterol) aerosol DULERA (mometasone furoate and formoterol fumarate dihydrate) aerosol

Staying Healthy. with Asthma. Illustrations by paulsharp.com

MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 07/05/18 SECTION: DRUGS LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE:

MANAGING ASTHMA. Nancy Davis, RRT, AE-C

Using Inhaled Corticosteroids as Needed for Asthma: giving patients relief or leaving them breathless?

Nancy Davis, RRT, AE-C

COPD Medicine. No one ever showed me how to use this. Wendy Happel; RRT, COPD Educator Krystal Fedoris; RRT-NPS, BA, COPD Educator

Drug Class Monograph

Commissioner for the Department for Medicaid Services Selections for Preferred Products

10/18/2012. Penn State University Children s Hospital JODIE STABINSKI CRNP MSN AE-C

Pain Oral-Intranasal Fentanyl (Abstral, Actiq, Fentora, Lazanda, Onsolis, Subsys)

Secretary for Health and Family Services Selections for Preferred Products

Aerospan (flunisolide)

See Important Reminder at the end of this policy for important regulatory and legal information.

Asthma/COPD Update with Inhaler Workshop

REVISED RESPIRATORY MEDICATION USE QUESTIONNAIRE

Common Inhaled Asthma Medications Dose Comparison and Tips for Use

12/18/2017. Disclosures. Asthma Management Updates: A Focus on Long-acting Muscarinic Antagonists and Intermittent Inhaled Corticosteroid Dosing

Women Beware-The Threat of COPD

STRIVERDI RESPIMAT (olodaterol hcl) aerosol

The Medical Letter. on Drugs and Therapeutics

Provider Respiratory Inservice

ANTINEOPLASTIC DRUGS CHAPTER 21. Antineoplastic drugs - designed to treat malignancies, now also used to treat diseases with inflammatory component

Methacholine Challenge Test

reslizumab (Cinqair )

Reference Guide for Caring for Pediatric Patients with Asthma

Breath of Fresh Air. nniversary 20th. New National Asthma Survey: How Does Your Asthma Compare? Long-Acting Bronchodilators: Why All the Fuss?

Asthma By Mayo Clinic staff

MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Asthma/COPD P&T DATE 12/14/2017 CLASS:

Women Beware The Threat of COPD

Correct Use of Inhaler Devices

Asthma Management Updates: A Focus on Long-acting Muscarinic Antagonists and Intermittent Inhaled Corticosteroid Dosing

Proposed Preferred Drug List. Clinical Criteria

Learning Objectives 4/26/2012. Review normal lung function and COPD pathophysiology Discuss pharmacological management

Key features and changes to these four components of asthma care include:

Drug Effectiveness Review Project Summary Report

Medications for Managing COPD in Hospice Patients. Jim Joyner, PharmD, CGP Director of Clinical Operations Outcome Resources

ASTHMA IN THE PEDIATRIC POPULATION

benralizumab (Fasenra )

Drug Class Review. Controller Medications for Asthma

MDI Bonanza. Dwayne Griffin, DO

Inhaled Corticosteroids Drug Class Prior Authorization Protocol

Drug Class Review. Controller Medications for Asthma

University System of Georgia Prior Authorization, Step Therapy and Quantity Limit List (Updated 1/1/2016)

Inhaled Corticosteroids Drug Class Prior Authorization Protocol

Q: Should patients with mild asthma

Asthma in Pregnancy. Asthma. Chronic Airway Inflammation. Objective Measures of Airflow. Peak exp. flow rate (PEFR)

Asthma. Introduc:on. Introduc:on. Anatomic Altera:ons of the Lungs. Introduc:on. RSPT 2310 Asthma RSPT 2310

agonist in patients 6 years and older with reversible airway disease and acute attacks of bronchospasm

Relative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*

CAMPER APPLICATION PACKET

Pequot Health Care Smart Quantity Program*

Drugs that Affect the Respiratory System BROOKE BENTLEY, PHD, APRN

4/3/2018 BRANDY BURGESS, APRN-CNS, MSN-RN APRIL 12-14, 2018

A Patient s Guide to Aerosol Medication Delivery

Pharmacy Medical Policy Asthma and Chronic Obstructive Pulmonary Disease Medication Management

Impact of a Comprehensive COPD Therapeutic Interchange Program on 30-Day Readmission Rates in Hospitalized Patients

Oregon Health Plan prescription benefit updates

Allergies and Asthma 5/21/2013. Objectives. Allergic Rhinitis (AR): Risk Factor for ASTHMA. Rhinitis and Asthma

Clinical Policy: Omalizumab (Xolair) Reference Number: ERX.SPA.141 Effective Date: Last Review Date: 08.17

Data Class: Internal. 1 inhaler (30 blisters OR 14 blisters institutional pack) per presciption

See Important Reminder at the end of this policy for important regulatory and legal information.

September 2009 Based on Data collected for the DERP report of 11/2008

Asthma. doh.sd.gov/statistics/2009brfss/asthma.pdf

Question I was one of the first dry power devices available in the US Flovent, Serevent and Advair are all available in this device

Respiratory Health. Asthma and COPD

APPENDIX 1 Printable point-of-care tables Asthma Action Plan Yellow Zone Formulation Table Region: Europe

Cinqair (reslizumab injection for intravenous use)

Taking Control of Asthma Through Proper Medication Selection and the Use of Asthma Action Plans Julie M. Koehler, Pharm.D., FCCP

How to Manage Asthma

CLINICAL MEDICAL POLICY

9/14/12. Nicole Paterson, PharmD BCPS Medication Therapy Management Provider Fairview Pharmacy Services, LLC

Asthma Pharmacotherapy 2017: Stepwise Approach to Managing Asthma

Nucala (mepolizumab injection for subcutaneous use)

QUANTITY LIMIT CRITERIA. BROVANA (arformoterol tartrate) SEREVENT DISKUS (salmeterol) STRIVERDI RESPIMAT (olodaterol)

Asthma & COPD Medication Review. Hutchison Disclosures 2/16/2017. Objectives

Bronchiectasis. Examples include: Viral infections (measles, adenovirus, influenza)

Improving Outcomes in COPD

Clinical Policy: Dupilumab (Dupixent) Reference Number: ERX.SPA.49 Effective Date:

Breath of Fresh Air. Information, news and advice for improving asthma well-being. National Asthma Guidelines: A Stepped Approach to Asthma Therapy

See Important Reminder at the end of this policy for important regulatory and legal information.

DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL

2014 Quantity Limits (QL) Criteria

Transcription:

Inhaled bronchodilators relax constricted airways and treat the noisy part of asthma: coughing, wheezing, choking and shortness of breath. AccuNeb inhalation 0.021% solution: 0.63mg/3mL 3-4 times solution 0.042% solution: 1.25 mg/3ml Advair Diskus 100/50 250/50 500/50 Advair HFA 45/21 115/21 230/21 Alent inhalation 100mcg /50mcg 250mcg /50mcg 500mcg /50mcg 45mcg /21mcg 115mcg /21mcg 230mcg /21mcg 0.021% solution: 0.63mg/3mL 0.042% solution: 1.25 mg/3ml 0.083% solution: 2.5mg/3mL. 5% solution: 2.5mg/0.5mL metaproterenol sulfate 3-4 times 65 mcg per inhalation 3-4 times 2 yrs & Dey L.P. 4 yrs & 2 yrs & 2 yrs & 2 yrs & GlaxoSmithKline Note: Advair does not replace fast-acting s for sudden symptoms and should not be taken more than twice a day. Advair HFA now has an integrated dose counter various manufacturers DISCONTINUED Charts Updated August 18, 2010 Copyright 2010 All Rights Reserved Page 1

Inhaled bronchodilators (continued) Atrovent HFA inhalation Brovana Combivent Dulera DuoNeb inhalation solution Foradil! Aerolizer ipratropium bromide HFA ar tartrate ipratroprium bromide and mometasone furoate and ipratroprium bromide and 21 mcg per inhalation 4 times 2 ml/2.1ml 18 mcg ipratropium bromide/ 103 mcg per inhalation 100 mcg mometasone/5 mcg 200 mcg mometasone/5 mcg 0.5mg ipratropium/3mg albuterol in 3mL unit dose vials 4 times 4-6 times 12 mcg per inhalation Note: Atrovent is not indicated for the initial treatment of acute episodes of bronchospasm where rapid response is required. Sepracor Note: Brovana is not indicated to relieve acute respiratory symptoms Merck Inc. Dey 5 yrs & Schering Corp. Note: Foradil is not indicated to relieve acute asthma symptoms. Charts Updated August 18, 2010 Copyright 2010 All Rights Reserved Page 2

Inhaled Bronchodilators (continued) ipratroprium bromide ipratropium bromide and Maxair" Autohaler metaproterenol sulfate Perforomist ipratroprium bromide ipratropium bromide and pirbuterol acetate metaproterenol sulfate breath-actuated ProAir HFA HFA Proventil! HFA Serevent! Diskus! xinafoate 0.02% solution: 0.5mg/2.5mL 0.5mg ipratropium/3mg albuterol in 3mL unit-dose vials 3-4 times 4-6 times 200 mcg per inhalation 3-4 times 0.4% solution: 10mg/2.5mL 0.6% solution: 15mg/2.5mL 3-4 times 20mcg/2mL 90 mcg per inhalation 3-4 times 108 mcg per inhalation 3-4 times 50 mcg per inhalation various various manufacturers 3M Pharmaceuticals various manufacturers Dey Note: Perforomist is not indicated to treat asthma or acute deteriorations of COPD 4 yrs & TEVA Respiratory 4 yrs & Schering Corp. 4 yrs & GlaxoSmithKline Note: Serevent should not be used to relieve acute asthma symptoms Charts Updated August 18, 2010 Copyright 2010 All Rights Reserved Page 3

Inhaled bronchodilators (continued) Spiriva HandiHaler Symbicort inhalation 80/4.5 160/4.5 tiotropium bromide budesonide and Ventolin HFA Xopenex inhalation solution Xopenex inhalation solution concentrate Xopenex HFA levalbuterol HCI levalbuterol tartrate 18 mcg per inhalation 1 time per day 80mcg budesonide/4.5mcg per inhalation 160mcg budesonide/4.5mcg per inhalation 108 mcg per inhalation 3-4 times 0.31mg/3mL unit-dose vial 0.63mg/3mL unit-dose vial 1.25mg/3mL 1.25mg/0.5mL 3 times 45 mcg per inhalation 3-4 times 12 yrs and Note: Spiriva is not indicated for the initial treatment of acute episodes of bronchospasm. AstraZeneca Note: Symbicort is not indicated for the relief of acute bronchospasm. manufacturers Symbicort (HFA) now has an integrated dose counter 4 yrs & GlaxoSmithKline Note: Ventolin HFA now has an integrated dose counter 6 yrs & 4 yrs & Sepracor Inc. Charts Updated August 18, 2010 Copyright 2010 All Rights Reserved Page 4

Inhaled corticosteroids and other anti-inflammatory medications reduce and prevent airway inflammation (swelling). Used daily, anti-inflammatories treat the underlying part of asthma patients may not feel. Advair Diskus 100/50 250/50 500/50 Advair HFA 45/21 115/21 230/21 AeroBid AeroBid -M (menthol) flunisolide Aerospan HFA flunisolide Alvesco HFA 80 mcg 160 mcg Asmanex Twisthaler 110 mcg 220 mcg Azmacort inhalation ciclesonide mometasone furoate triamcinolone acetonide 100mcg /50mcg 250mcg /50mcg 500mcg /50mcg 45mcg /21mcg 115mcg /21mcg 230mcg /21mcg 250 mcg per inhalation 80 mcg per inhalation 80 mcg per inhalation 160 mcg per inhalation 1-110 mcg per inhalation 220 mcg per inhalation 100 mcg per inhalation 2-4 times 4 yrs & Charts Updated August 18, 2010 Copyright 2010 All Rights Reserved Page 5 GlaxoSmithKline Note: Advair does not replace fast-acting s for sudden symptoms and should not be taken more than twice a day. Advair HFA now has an integrated dose counter 6 yrs & Forest Pharmaceuticals Inc. 6 yrs & Acton Pharmaceuticals NOT YET AVAILABLE Sepracor Inc. 4 yrs & Schering Corp. 6 yrs & Kos Pharmaceuticals DISCONTINUED

Inhaled corticosteroids and other anti-inflammatories (continued) cromolyn sodium Dulera Flovent Diskus 50 mcg 100 mcg 250 mcg Flovent HFA 44 mcg 110 mcg 220 mcg Intal Inhaler cromolyn sodium mometasone furoate and formoerol propionate cromolyn sodium 10mg/mL 4 times 100 mcg mometasone/5 mcg 200 mcg mometasone/5 mcg 50 mcg per inhalation 100 mcg per inhalation 250 mcg per inhalation 44 mcg per inhalation 110 mcg per inhalation 220 mcg per inhalation 800 mcg per inhalation 4 times Pulmicort Respules budesonide 0.25mg/2mL unit-dose ampule 0.5mg/2mL unit-dose ampule 1mg/2mL unit-dose ampule Pulmicort Flexhaler 90 mcg per inhalation 90 mcg 180 mcg per inhalation 180 mcg QVAR 40 mcg 80 mcg Symbicort inhalation 80/4.5 160/4.5 beclomethasone dipropionate HFA budesonide and 40 mcg per inhalation 80 mcg per inhalation 80mcg budesonide/4.5mcg per inhalation 160mcg budesonide/4.5mcg per inhalation 1- a day 2 yrs & various manufacturers Merck Inc. Note: Dulera has an integrated dose counter 4 yrs & GlaxoSmithKline Note: Flovent HFA now has an integrated dose counter 5 & King Pharmaceuticals DISCONTINUED 12 months 8 yrs 6 yrs & AstraZeneca LP 5 yrs & Teva Specialty Pharmaceuticals LLC AstraZeneca Note: Symbicort is not indicated for the relief of acute bronchospasm. Charts Updated August 18, 2010 Copyright 2010 All Rights Reserved Page 6

Leukotriene Modifiers Accolate zafirlukast tablets 10 mg tablets 20 mg tablets Singulair montelukast tablets 4 mg chewable tablets 1 time per sodium 5 mg chewable tablets day 10 mg coated tablets granules 4 mg packets Zyflo zileuton tablets 600 mg tablets 4 times Zyflo CR extended release tablets 5 yrs & AstraZeneca 12 mos & Merck & Co. Inc. Cornerstone Therapeutics Charts Updated August 18, 2010 Copyright 2010 All Rights Reserved Page 7